144 related articles for article (PubMed ID: 9169078)
1. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation.
Andersen ME; Birnbaum LS; Barton HA; Eklund CR
Toxicol Appl Pharmacol; 1997 May; 144(1):145-55. PubMed ID: 9169078
[TBL] [Abstract][Full Text] [Related]
2. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
[TBL] [Abstract][Full Text] [Related]
3. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction.
Drahushuk AT; McGarrigle BP; Tai HL; Kitareewan S; Goldstein JA; Olson JR
Toxicol Appl Pharmacol; 1996 Oct; 140(2):393-403. PubMed ID: 8887457
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
5. Differential time-course and dose-response relationships of TCDD-induced CYP1B1, CYP1A1, and CYP1A2 proteins in rats.
Santostefano MJ; Ross DG; Savas U; Jefcoate CR; Birnbaum LS
Biochem Biophys Res Commun; 1997 Apr; 233(1):20-4. PubMed ID: 9144388
[TBL] [Abstract][Full Text] [Related]
6. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8 Tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes.
Xu L; Li AP; Kaminski DL; Ruh MF
Chem Biol Interact; 2000 Feb; 124(3):173-89. PubMed ID: 10728777
[TBL] [Abstract][Full Text] [Related]
8. A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: dose- and time-dependent effects.
Santostefano MJ; Wang X; Richardson VM; Ross DG; DeVito MJ; Birnbaum LS
Toxicol Appl Pharmacol; 1998 Aug; 151(2):294-310. PubMed ID: 9707506
[TBL] [Abstract][Full Text] [Related]
9. Physiological modeling of a proposed mechanism of enzyme induction by TCDD.
Kohn MC; Walker NJ; Kim AH; Portier CJ
Toxicology; 2001 May; 162(3):193-208. PubMed ID: 11369115
[TBL] [Abstract][Full Text] [Related]
10. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
[TBL] [Abstract][Full Text] [Related]
11. Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter.
Conolly RB; Andersen ME
Toxicol Appl Pharmacol; 1997 Oct; 146(2):281-93. PubMed ID: 9344896
[TBL] [Abstract][Full Text] [Related]
12. Responsiveness of the adult male rat reproductive tract to 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: Ah receptor and ARNT expression, CYP1A1 induction, and Ah receptor down-regulation.
Roman BL; Pollenz RS; Peterson RE
Toxicol Appl Pharmacol; 1998 Jun; 150(2):228-39. PubMed ID: 9653054
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent localization of TCDD in isolated centrilobular and periportal hepatocytes.
Santostefano MJ; Richardson VM; Walker NJ; Blanton J; Lindros KO; Lucier GW; Alcasey SK; Birnbaum LS
Toxicol Sci; 1999 Nov; 52(1):9-19. PubMed ID: 10568693
[TBL] [Abstract][Full Text] [Related]
14. Determination of parameters responsible for pharmacokinetic behavior of TCDD in female Sprague-Dawley rats.
Wang X; Santostefano MJ; Evans MV; Richardson VM; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 1997 Nov; 147(1):151-68. PubMed ID: 9356318
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity analysis of a physiological model for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): assessing the impact of specific model parameters on sequestration in liver and fat in the rat.
Evans MV; Andersen ME
Toxicol Sci; 2000 Mar; 54(1):71-80. PubMed ID: 10746933
[TBL] [Abstract][Full Text] [Related]
16. A dioxin-responsive enhancer 3' of the human CYP1A2 gene.
Okino ST; Quattrochi LC; Pookot D; Iwahashi M; Dahiya R
Mol Pharmacol; 2007 Dec; 72(6):1457-65. PubMed ID: 17785579
[TBL] [Abstract][Full Text] [Related]
17. A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: tissue distribution and CYP1A induction.
Kedderis LB; Mills JJ; Andersen ME; Birnbaum LS
Toxicol Appl Pharmacol; 1993 Jul; 121(1):87-98. PubMed ID: 8337704
[TBL] [Abstract][Full Text] [Related]
18. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction.
Vanden Heuvel JP; Clark GC; Kohn MC; Tritscher AM; Greenlee WF; Lucier GW; Bell DA
Cancer Res; 1994 Jan; 54(1):62-8. PubMed ID: 8261464
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the rabbit CYP1A1 and CYP1A2 genes: developmental and dioxin-inducible expression of rabbit liver P4501A1 and P4501A2.
Strom DK; Postlind H; Tukey RH
Arch Biochem Biophys; 1992 May; 294(2):707-16. PubMed ID: 1567227
[TBL] [Abstract][Full Text] [Related]
20. Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in the livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteria.
Walker NJ; Crofts FG; Li Y; Lax SF; Hayes CL; Strickland PT; Lucier GW; Sutter TR
Carcinogenesis; 1998 Mar; 19(3):395-402. PubMed ID: 9525272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
